MESSAGE FROM BEXIL
Letter from the President
Overview
    COMMUNICATIONS
Press Releases
Bexil in the News
Shareholder Reports and Proxy Statements
Rule 15c2-11 Information
Investor Conference Calls
    GOVERNANCE
Board of Directors
Executives
Other Governance Info
    CONTACT US
Contact Bexil
Contact Transfer Agent
 
 
 
 
 
 
 
 
 
 
 
 
 

Rule 15c2-11 Information

1. The exact name of the issuer and its predecessor (if any):  Bexil Corporation

2. The address of its principal executive offices:  
        PO Box 4
        Walpole, NH 03608

3. The state of incorporation, if it is a corporation:  Maryland

4. The exact title and class of the security:  
        Common Stock, $.01 par value
        Rights to Purchase Series A Participating Preferred Stock, $.01 par value

5. The number of shares or total amount of the securities outstanding as of the end of the issuer's most recent fiscal year:

        Common Stock, 9,900,000 shares authorized, 980,245 issued and outstanding as of September 30, 2013.
        Rights to Purchase Series A Participating Preferred Stock, 100,000 shares authorized, 0 shares issued and outstanding as of September 30, 2013.

6. The name and address of the transfer agent:  
        IST Shareholder Services
        433 S Carlton Avenue
        Wheaton, IL 60187-9904

7. The nature of the issuer's business:  Holding company.

8. The nature of products or services offered:  Bexil Corporation is a holding company

9. The nature and extent of the issuer's facilities:  leased office space at PO Box 4, Walpole, NH 03608   

10. The name of the chief executive officer and members of the board of directors:
        CEO – Thomas B. Winmill.
        Members of the Board of Directors – Charles A. Carroll, Douglas Wu, Thomas B. Winmill

11. The issuer's most recent balance sheet and profit and loss and retained earnings statements:  See the Company's most recent annual report.

12. Similar financial information for such part of the 2 preceding fiscal years as the issuer or its predecessor has been in existence: See the Company's most recent annual report.



PO Box 4, Walpole, NH 03608 Tel: 1-212-785-0900 Fax: 1-917-746-4802
Home   |   Contact
www.Bexil.com